Thrivent Financial for Lutherans’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.12M Buy
91,276
+400
+0.4% +$4.91K ﹤0.01% 1717
2025
Q1
$2M Sell
90,876
-2,551
-3% -$56.1K ﹤0.01% 1289
2024
Q4
$2.12M Buy
93,427
+38,597
+70% +$875K ﹤0.01% 1391
2024
Q3
$996K Sell
54,830
-2,082
-4% -$37.8K ﹤0.01% 1914
2024
Q2
$1.66M Buy
56,912
+39,868
+234% +$1.16M ﹤0.01% 1516
2024
Q1
$604K Buy
17,044
+53
+0.3% +$1.88K ﹤0.01% 2157
2023
Q4
$740K Sell
16,991
-742
-4% -$32.3K ﹤0.01% 2028
2023
Q3
$677K Sell
17,733
-659
-4% -$25.2K ﹤0.01% 1986
2023
Q2
$756K Sell
18,392
-4,050
-18% -$166K ﹤0.01% 1977
2023
Q1
$1.29M Sell
22,442
-178
-0.8% -$10.2K ﹤0.01% 1621
2022
Q4
$1.27M Sell
22,620
-3,889
-15% -$218K ﹤0.01% 1580
2022
Q3
$1.12M Sell
26,509
-10,151
-28% -$430K ﹤0.01% 1614
2022
Q2
$1.98M Sell
36,660
-277
-0.7% -$15K 0.01% 1236
2022
Q1
$2.37M Sell
36,937
-787
-2% -$50.6K ﹤0.01% 1220
2021
Q4
$2.53M Sell
37,724
-487
-1% -$32.6K ﹤0.01% 1235
2021
Q3
$2.62M Buy
38,211
+46
+0.1% +$3.15K 0.01% 1187
2021
Q2
$2.6M Buy
38,165
+13
+0% +$887 0.01% 1249
2021
Q1
$2.64M Sell
38,152
-636
-2% -$43.9K 0.01% 1229
2020
Q4
$2.52M Buy
38,788
+19,733
+104% +$1.28M 0.01% 1171
2020
Q3
$900K Sell
19,055
-398
-2% -$18.8K ﹤0.01% 1631
2020
Q2
$914K Buy
19,453
+831
+4% +$39K ﹤0.01% 1560
2020
Q1
$832K Hold
18,622
﹤0.01% 1411
2019
Q4
$1.09M Buy
18,622
+190
+1% +$11.1K ﹤0.01% 1420
2019
Q3
$1.11M Sell
18,432
-269
-1% -$16.2K ﹤0.01% 1340
2019
Q2
$1.04M Buy
18,701
+387
+2% +$21.6K ﹤0.01% 1370
2019
Q1
$1.02M Buy
18,314
+362
+2% +$20.2K ﹤0.01% 1358
2018
Q4
$810K Buy
17,952
+942
+6% +$42.5K ﹤0.01% 1296
2018
Q3
$1.12M Buy
17,010
+937
+6% +$61.7K ﹤0.01% 1200
2018
Q2
$1.04M Sell
16,073
-26,718
-62% -$1.72M ﹤0.01% 1233
2018
Q1
$2.37M Buy
42,791
+3,517
+9% +$195K 0.01% 839
2017
Q4
$1.88M Buy
39,274
+774
+2% +$37.1K 0.01% 938
2017
Q3
$1.94M Buy
38,500
+1,840
+5% +$92.9K 0.01% 874
2017
Q2
$2M Buy
36,660
+2,880
+9% +$157K 0.01% 819
2017
Q1
$1.42M Buy
33,780
+1,620
+5% +$68.2K 0.01% 986
2016
Q4
$1.38M Buy
32,160
+1,720
+6% +$73.8K 0.01% 997
2016
Q3
$1.26M Buy
30,440
+2,020
+7% +$83.3K 0.01% 1036
2016
Q2
$1.13M Buy
28,420
+1,900
+7% +$75.8K 0.01% 1052
2016
Q1
$893K Buy
26,520
+1,600
+6% +$53.9K ﹤0.01% 1120
2015
Q4
$845K Buy
24,920
+1,420
+6% +$48.2K ﹤0.01% 1123
2015
Q3
$700K Sell
23,500
-598
-2% -$17.8K ﹤0.01% 1071
2015
Q2
$664K Buy
24,098
+1,223
+5% +$33.7K ﹤0.01% 970
2015
Q1
$576K Buy
22,875
+490
+2% +$12.3K ﹤0.01% 1043
2014
Q4
$496K Buy
22,385
+122
+0.5% +$2.7K ﹤0.01% 1116
2014
Q3
$452K Buy
22,263
+1,101
+5% +$22.4K ﹤0.01% 1154
2014
Q2
$407K Buy
21,162
+122
+0.6% +$2.35K ﹤0.01% 1226
2014
Q1
$396K Hold
21,040
﹤0.01% 1078
2013
Q4
$410K Buy
21,040
+2,936
+16% +$57.2K ﹤0.01% 1075
2013
Q3
$298K Buy
18,104
+245
+1% +$4.03K ﹤0.01% 1224
2013
Q2
$267 Buy
+17,859
New +$267 ﹤0.01% 1272